搜索临床试验以:SENS-401
总计5435个结果
-
Aevi Genomic Medicine, LLC, a Cerecor company完全的
-
Cerenis Therapeutics, SASouth Australian Health and Medical Research Institute完全的
-
Hospital General Universitario Elche完全的
-
The Hong Kong Polytechnic University完全的
-
University Hospital of CologneUniversitätsklinikum Hamburg-Eppendorf尚未招聘
-
Linkoeping UniversityUniversity Hospital, Linkoeping; Sodra Alvsborgs Hospital; University of Boras完全的中风 | 脑瘫 | 痉挛
-
Parker Institute for Cancer ImmunotherapySeres Therapeutics, Inc.完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Bellicum Pharmaceuticals撤销复发性急性髓性白血病 | 复发性慢性粒单核细胞白血病 | 复发性骨髓增生异常综合征 | 复发性急性淋巴细胞白血病 | 复发性慢性粒细胞白血病,BCR-ABL1 阳性 | 骨髓增殖性肿瘤 | 骨髓增生异常/骨髓增生性肿瘤 | 骨髓增生异常/骨髓增生性肿瘤,无法分类 | 急性双系白血病 | 复发性急性双表型白血病 | 复发性慢性淋巴细胞白血病 | 复发性母细胞性浆细胞样树突状细胞肿瘤美国
-
ImmuneOncia Therapeutics Inc.尚未招聘TMB-H | 组织学或细胞学证明的转移性或局部晚期实体瘤
-
Leiden University Medical Center招聘中
-
Marker Therapeutics, Inc.招聘中
-
Antengene (Hangzhou) Biologics Co., Ltd.招聘中
-
Pacylex PharmaceuticalsOzmosis Research Inc.招聘中
-
Major Extremity Trauma Research ConsortiumUnited States Department of Defense招聘中
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical University邀请报名
-
Tvardi Therapeutics, IncorporatedM.D. Anderson Cancer Center主动,不招人
-
Verve Therapeutics, Inc.主动,不招人
-
LogicBio Therapeutics, IncAlexion Pharmaceuticals, Inc.终止